Yanaika S. Hok‐A‐Hin

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

Marta del Campo, Carel F.W. Peeters, Erik C. B. Johnson et al. · Nature Aging · 2022 · 91 citations · Full text

Proteomic Technology, Neurodegenerative Diseases, Csf Proteome Profiling +12

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

Marta del Campo, Lisa Vermunt, Carel F.W. Peeters et al. · Nature Communications · 2023 · 63 citations · Full text

Neurochemical Biomarkers, Neurobiology Of Disease, Neurology +20

CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease

Emma L. van der Ende, Sjors G. J. G. In ‘t Veld, Iris Hanskamp et al. · Brain · 2023 · 49 citations · Full text

Csf Proteomics, Autosomal Dominant Alzheimer, Disease Highlights Parallels +19

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease

Yanaika S. Hok‐A‐Hin, Marta del Campo, Walter Boiten et al. · Journal of Neuroinflammation · 2023 · 37 citations · Full text

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias

Katharina Bolsewig, Yanaika S. Hok‐A‐Hin, Federica Nicoletta Sepe et al. · Journal of Alzheimer s Disease · 2022 · 36 citations · Full text